Real-World Results of GLP-1 Drugs for Overweight Diabetes Patients in Romania
In 311 Romanian patients with type 2 diabetes and excess weight, GLP-1 drugs improved blood sugar, body weight, and waist circumference in real-world practice.
Quick Facts
What This Study Found
All GLP-1 RAs studied improved HbA1c, body weight, and waist circumference in real-world Romanian clinical practice.
Key Numbers
N=311; HbA1c >7.2% and BMI >=25 at baseline; all treatments significantly improved HbA1c, BMI, and WC at 6 months (p values significant).
How They Did This
Prospective observational study of 311 T2DM adults monitoring HbA1c, body weight, and waist circumference on various GLP-1 RAs.
Why This Research Matters
Clinical trial results don't always translate to real-world settings — this confirms GLP-1 drug effectiveness in routine Romanian clinical practice.
The Bigger Picture
Real-world data from diverse healthcare systems strengthens the global evidence base for GLP-1 drug guidelines.
What This Study Doesn't Tell Us
Observational design without control group. Single-country cohort may not generalize to all healthcare settings.
Questions This Raises
- ?Which GLP-1 RA performed best in this Romanian cohort?
- ?Do results differ between oral and injectable semaglutide in real-world use?
Trust & Context
- Key Stat:
- 311 patients Prospective real-world Romanian cohort on 4 different GLP-1 receptor agonists
- Evidence Grade:
- Prospective observational study — better than retrospective but lacks randomization and control group.
- Study Age:
- Published in 2025, reflecting current GLP-1 prescribing patterns in Romania.
- Original Title:
- Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.
- Published In:
- Biomedicines, 13(9) (2025)
- Authors:
- Popoviciu, Mihaela Simona, Reurean-Pintilei, Delia, Salmen, Teodor(2), Rus, Marius, Ferician, Anca, Sava, Cristian, Ardelean, Adriana Ioana, Moroianu, Lavinia-Alexandra, Pantea Stoian, Anca
- Database ID:
- RPEP-13087
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Do GLP-1 drugs work as well in real life as in clinical trials?
This Romanian study confirms real-world improvements in blood sugar, weight, and waist circumference across multiple GLP-1 medications.
Which GLP-1 drug is best?
The study compared exenatide, semaglutide (oral and injectable), and dulaglutide — all showed effectiveness in real-world use.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13087APA
Popoviciu, Mihaela Simona; Reurean-Pintilei, Delia; Salmen, Teodor; Rus, Marius; Ferician, Anca; Sava, Cristian; Ardelean, Adriana Ioana; Moroianu, Lavinia-Alexandra; Pantea Stoian, Anca. (2025). Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.. Biomedicines, 13(9). https://doi.org/10.3390/biomedicines13092174
MLA
Popoviciu, Mihaela Simona, et al. "Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs.." Biomedicines, 2025. https://doi.org/10.3390/biomedicines13092174
RethinkPeptides
RethinkPeptides Research Database. "Translating Guidelines into Practice: A Prospective Real-Wor..." RPEP-13087. Retrieved from https://rethinkpeptides.com/research/popoviciu-2025-translating-guidelines-into-practice
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.